Dihydroergotamine

ATZUMI, BREKIYA, Trudhesa

Ergotamine Derivative

NADAC/unit $34.8394

No Shortage PA Req: 0.3% 9 Manufacturers 10 ANDAs

vs. brand ATZUMI: Generic saves up to -248% per unit

Covered Lives

Market Intelligence

2024-12-25 Class II Recall: Provepharm Inc.

Generic Manufacturers

AMNEAL PHARMACEUTICALS LLCBAUSCH HEALTH US LLCCIPLA LTDGLAND PHARMA LTDHIKMA PHARMACEUTICALSHIKMA PHARMACEUTICALS USA INCIMPEL PHARMACEUTICALS LLCMILLA PHARMACEUTICALS INCPADAGIS US LLCRUBICON RESEARCH LTDSAGENT PHARMACEUTICALS INCSATSUMA PHARMACEUTICALS INCSOMERSET THERAPEUTICS LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Dihydroergotamine drfinder.aiFind doctors who prescribe Dihydroergotamine rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Dihydroergotamine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.